What does CUSIP 427746102 represent in this 13F holders report?

CUSIP 427746102 is the security identifier for HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock used to aggregate holder disclosures.

How many institutions held HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in Q2 2016?

90 institutional investors reported HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock for Q2 2016. Use the holders table for investor-level position and value details.

- Common Stock (HRTX)

CUSIP: 427746102

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class: Equity / Common Stock
Shares outstanding: 182,615,507
Total 13F shares: 46,993,886
Share change: +1,978,063
Total reported value: $848,220,501
Put/Call ratio: 28%
Price per share: $18.05
Number of holders: 90
Value change: +$35,391,534
Number of buys: 49
Number of sells: 35

Quarterly Holders Quick Answers

What is CUSIP 427746102?
CUSIP 427746102 identifies HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2016
Previous quarter: Q1 2016

Recent filing periods for CUSIP 427746102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FRANKLIN RESOURCES INC	13F	Company	4.1%	7,523,278	$142,869,000	—	31 Mar 2016	13F
FMR LLC	13F	Company	3%	5,429,452	$103,105,000	—	31 Mar 2016	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	2.8%	5,190,837	$98,574,000	—	31 Mar 2016	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	1.9%	3,497,755	$66,424,000	—	31 Mar 2016	13F
Invesco Ltd.	13F	Company	1.7%	3,146,208	$59,746,000	—	31 Mar 2016	13F
PFM Health Sciences, LP	13F	Company	1.7%	3,073,470	$58,365,000	—	31 Mar 2016	13F
BAKER BROS. ADVISORS LP	13F	Company	1.6%	2,907,784	$55,219,000	—	31 Mar 2016	13F
Cormorant Asset Management, LP	13F	Company	0.96%	1,750,000	$33,233,000	—	31 Mar 2016	13F
Broadfin Capital, LLC	13F	Company	0.8%	1,465,475	$27,829,000	—	31 Mar 2016	13F
STATE STREET CORP	13F	Company	0.66%	1,208,572	$22,947,000	—	31 Mar 2016	13F
VANGUARD GROUP INC	13F	Company	0.63%	1,157,304	$21,978,000	—	31 Mar 2016	13F
VHCP Management, LLC	13F	Company	0.6%	1,095,734	$20,808,000	—	31 Mar 2016	13F
BlackRock Fund Advisors	13F	Company	0.41%	757,175	$14,379,000	—	31 Mar 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.39%	714,241	$13,563,000	—	31 Mar 2016	13F
Allianz Asset Management GmbH	13F	Company	0.26%	472,678	$8,976,000	—	31 Mar 2016	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.24%	433,084	$8,224,000	—	31 Mar 2016	13F
VHCP Management II, LLC	13F	Company	0.22%	405,901	$7,708,000	—	31 Mar 2016	13F
JPMORGAN CHASE & CO	13F	Company	0.19%	348,685	$6,622,000	—	31 Mar 2016	13F
NORTHERN TRUST CORP	13F	Company	0.19%	341,584	$6,487,000	—	31 Mar 2016	13F
BROWN ADVISORY INC	13F	Company	0.16%	296,356	$5,628,000	—	31 Mar 2016	13F
Asset Management One Co., Ltd.	13F	Company	0.15%	278,864	$5,401,000	—	31 Mar 2016	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.13%	245,392	$4,660,000	—	31 Mar 2016	13F
Tekla Capital Management LLC	13F	Company	0.12%	219,000	$4,159,000	—	31 Mar 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.11%	207,789	$3,945,000	—	31 Mar 2016	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.09%	171,233	$3,252,000	—	31 Mar 2016	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.09%	169,894	$3,226,000	—	31 Mar 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.08%	154,671	$2,937,000	—	31 Mar 2016	13F
Bank of New York Mellon Corp	13F	Company	0.08%	143,407	$2,723,000	—	31 Mar 2016	13F
UBS Group AG	13F	Company	0.08%	139,623	$2,651,000	—	31 Mar 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.06%	104,630	$1,987,000	—	31 Mar 2016	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.06%	104,617	$1,987,000	—	31 Mar 2016	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.06%	102,996	$1,956,000	—	31 Mar 2016	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.05%	100,000	$1,899,000	—	31 Mar 2016	13F
TURNER INVESTMENTS LLC	13F	Company	0.05%	96,570	$1,834,000	—	31 Mar 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.05%	88,990	$1,690,000	—	31 Mar 2016	13F
Brandywine Global Investment Management, LLC	13F	Company	0.04%	74,085	$1,407,000	—	31 Mar 2016	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.04%	72,059	$1,368,000	—	31 Mar 2016	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.04%	68,700	$1,305,000	—	31 Mar 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.04%	65,905	$1,250,000	—	31 Mar 2016	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	61,900	$1,175,000	—	31 Mar 2016	13F
GAM Holding AG	13F	Company	0.03%	59,100	$1,122,000	—	31 Mar 2016	13F
TEACHERS ADVISORS, LLC	13F	Company	0.03%	58,473	$1,110,000	—	31 Mar 2016	13F
CREDIT SUISSE AG/	13F	Company	0.03%	55,020	$1,045,000	—	31 Mar 2016	13F
D. E. Shaw & Co., Inc.	13F	Company	0.03%	49,670	$943,000	—	31 Mar 2016	13F
Partner Investment Management, L.P.	13F	Company	0.03%	49,049	$931,000	—	31 Mar 2016	13F
Swiss National Bank	13F	Company	0.03%	50,400	$925,000	—	31 Mar 2016	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	47,400	$900,000	—	31 Mar 2016	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	46,299	$879,000	—	31 Mar 2016	13F
AXA S.A.	13F	Company	0.02%	43,820	$832,000	—	31 Mar 2016	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.02%	41,409	$786,000	—	31 Mar 2016	13F

Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q2 2016

As of 30 Jun 2016, HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by 90 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,993,886 shares. The largest 10 holders included FRANKLIN RESOURCES INC, TANG CAPITAL MANAGEMENT LLC, FMR LLC, JANUS CAPITAL MANAGEMENT LLC, Partner Fund Management, L.P., Invesco Ltd., BAKER BROS. ADVISORS LP, Cormorant Asset Management, LLC, Broadfin Capital, LLC, and VANGUARD GROUP INC. This page lists 90 institutional shareholders reporting positions in this security for the Q2 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2016 vs Q1 2016 Across Filers

Q1 2016 holders

Q2 2016 holders

Holder diff

-8

Investor	Q1 2016 Shares	Q2 2016 Shares	Share Diff	Share Chg %	Q1 2016 Value $	Q2 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.